Abstract C63: Biological characterization of GSK2126458, a novel and potent inhibitor of phosphoinositide 3-kinase and the mammalian target of rapamycin (mTOR)
Year: 2009
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Mary Ann Hardwicke, Hong Lu, Lusong Luo, Melody Diamond, Chiu-Mei Sung, Jeffrey D. Carson, Ramona Plant, Christine Gardiner, Jamin Wang, Catherine A. Oleykowski, Richard Gontarek, Glenn Van Aller, Seth Gilbert, David S. Sutton, Peter J. Tummino, Richard F. Wooster, Steven D. Knight, Jeffrey R. Jackson, Dashyant Dhanak, Kurt R. Auger
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2014865890
